Success Metrics

Clinical Success Rate
100.0%

Based on 4 completed trials

Completion Rate
100%(4/4)
Active Trials
1(10%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_2
4
40%
Ph phase_3
1
10%
Ph phase_1
5
50%

Phase Distribution

5

Early Stage

4

Mid Stage

1

Late Stage

Phase Distribution10 total trials
Phase 1Safety & dosage
5(50.0%)
Phase 2Efficacy & side effects
4(40.0%)
Phase 3Large-scale testing
1(10.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

4 of 4 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

10

all time

Status Distribution
Active(2)
Completed(4)
Other(4)

Detailed Status

Completed4
unknown4
Not yet recruiting1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
1
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 15 (50.0%)
Phase 24 (40.0%)
Phase 31 (10.0%)

Trials by Status

completed440%
not_yet_recruiting110%
unknown440%
recruiting110%

Recent Activity

1 active trials
Showing 5 of 10
recruitingphase_3

A Phase III Study of CM326 in Subjects With Moderate to Severe Asthma

NCT07372287
completedphase_1

A Study of CM326 in Patients With Chronic Rhinosinusitis With Nasal Polyps

NCT05324137
completedphase_1

Study of CM326 Injection in Healthy Subjects

NCT05715333
not_yet_recruitingphase_2

Study of CM326 in Participants With Chronic Rhinosinusitis With Nasal Polyposis

NCT06372678
unknownphase_2

A Study of CM326 in Subjects With Moderate to Severe Asthma

NCT05774340
View all 10 trials

Clinical Trials (10)

Showing 10 of 10 trials
NCT07372287Phase 3

A Phase III Study of CM326 in Subjects With Moderate to Severe Asthma

Recruiting
NCT05324137Phase 1

A Study of CM326 in Patients With Chronic Rhinosinusitis With Nasal Polyps

Completed
NCT05715333Phase 1

Study of CM326 Injection in Healthy Subjects

Completed
NCT06372678Phase 2

Study of CM326 in Participants With Chronic Rhinosinusitis With Nasal Polyposis

Not Yet Recruiting
NCT05774340Phase 2

A Study of CM326 in Subjects With Moderate to Severe Asthma

Unknown
NCT05671445Phase 2

The Study of CM326 in Adult Subjects With Atopic Dermatitis

Unknown
NCT05171348Phase 1

A Multiple Ascending Doses Study of CM326 Injection in Healthy Subjects

Completed
NCT05671432Phase 2

The Study of CM326 in Moderate-to-severe Atopic Dermatitis

Unknown
NCT04842201Phase 1

Single Ascending Dose Study of CM326 in Healthy Volunteers

Completed
NCT05186922Phase 1

The Study of CM326 in Patients With Moderate-to-severe Atopic Dermatitis

Unknown

All 10 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
10